Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glittre ADL-test Responsiveness to Bronchodilation in COPD
NCT03071731Unknown
- Sponsor
- Université Laval
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ipratropium bromide and salbutamol in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Primary endpoint: Glittre ADL-test time completion. Status: unknown.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03071731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071731.